Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course
de Vries-Huizing, Daphne M V, Versleijen, Michelle W J, Sinaasappel, Michiel, Walraven, Iris, Geluk-Jonker, Martine M, Tesselaar, Margot E T, Hendrikx, Jeroen J M A, de Wit-van der Veen, Berlinda J, Stokkel, Marcel P M
Published in PloS one (18.11.2021)
Published in PloS one (18.11.2021)
Get full text
Journal Article
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Aalbersberg, Else A., van Andel, Lotte, Geluk-Jonker, Martine M., Beijnen, Jos H., Stokkel, Marcel P. M., Hendrikx, Jeroen J. M. A.
Published in EJNMMI radiopharmacy and chemistry (01.05.2020)
Published in EJNMMI radiopharmacy and chemistry (01.05.2020)
Get full text
Journal Article
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling
Siebinga, Hinke, Hendrikx, Jeroen J. M. A., Huitema, Alwin D. R., de Wit-van der Veen, Berlinda J.
Published in EJNMMI research (15.06.2023)
Published in EJNMMI research (15.06.2023)
Get full text
Journal Article
Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
van Brandwijk, Elke A., Aalbersberg, Else A., Hosseini, Arman S., Huitema, Alwin D. R., Hendrikx, Jeroen J. M. A.
Published in EJNMMI radiopharmacy and chemistry (17.04.2024)
Published in EJNMMI radiopharmacy and chemistry (17.04.2024)
Get full text
Journal Article
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Siebinga, Hinke, Veerman, Chayenne H. A. M., de Wit-van der Veen, Linda, Stokkel, Marcel P. M., Hendrikx, Jeroen J. M. A., Aalbersberg, Else A.
Published in EJNMMI research (14.12.2022)
Published in EJNMMI research (14.12.2022)
Get full text
Journal Article
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Beijnen, Jos H., Dorlo, Thomas P. C., Huitema, Alwin D. R., Hendrikx, Jeroen J. M. A.
Published in EJNMMI research (03.02.2023)
Published in EJNMMI research (03.02.2023)
Get full text
Journal Article
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
Hooijman, Eline L., Ntihabose, Carolline M., Reuvers, Thom G. A., Nonnekens, Julie, Aalbersberg, Else A., van de Merbel, Jordy R. J. P., Huijmans, Judith E., Koolen, Stijn L. W., Hendrikx, Jeroen J. M. A., de Blois, Erik
Published in EJNMMI radiopharmacy and chemistry (04.11.2022)
Published in EJNMMI radiopharmacy and chemistry (04.11.2022)
Get full text
Journal Article
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
Siebinga, Hinke, de Wit-van der Veen, Berlinda J., Beijnen, Jos H., Stokkel, Marcel P. M., Dorlo, Thomas P. C., Huitema, Alwin D. R., Hendrikx, Jeroen J. M. A.
Published in EJNMMI physics (24.08.2023)
Published in EJNMMI physics (24.08.2023)
Get full text
Journal Article
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab
Malmberg, Ruben, Zietse, Michiel, Dumoulin, Daphne W, Hendrikx, Jeroen J M A, Aerts, Joachim G J V, van der Veldt, Astrid A M, Koch, Birgit C P, Sleijfer, Stefan, van Leeuwen, Roelof W F
Published in The lancet oncology (01.12.2022)
Published in The lancet oncology (01.12.2022)
Get full text
Journal Article
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Alves, Francisco, Antunes, Inês F., Cazzola, Emiliano, Cleeren, Frederik, Cornelissen, Bart, Denkova, Antonia, Engle, Jonathan, Faivre-Chauvet, Alain, Gillings, Nic, Hendrikx, Jeroen J. M. A., Jalilian, Amir R., van der Meulen, Nicholas P., Mikolajczak, Renata, Neels, Oliver C., Pillai, Maroor R. A., Reilly, Raymond, Rubow, Sietske, Seimbille, Yann, Spreckelmeyer, Sarah, Szymanski, Wiktor, Taddei, Carlotta
Published in EJNMMI radiopharmacy and chemistry (08.09.2021)
Published in EJNMMI radiopharmacy and chemistry (08.09.2021)
Get full text
Journal Article
P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel
Hendrikx, Jeroen J.M.A., Lagas, Jurjen S., Rosing, Hilde, Schellens, Jan H.M., Beijnen, Jos H., Schinkel, Alfred H.
Published in International journal of cancer (15.05.2013)
Published in International journal of cancer (15.05.2013)
Get full text
Journal Article
A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute
Heinhuis, Kimberley M., Barkman, Hannerieke J., Beijnen, Jos H., Hendrikx, Jeroen J. M. A.
Published in International journal of clinical pharmacy (01.02.2021)
Published in International journal of clinical pharmacy (01.02.2021)
Get full text
Journal Article
Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours
Vermunt, Marit A. C., van der Heijden, Lisa T., Hendrikx, Jeroen J. M. A., Schinkel, Alfred H., de Weger, Vincent A., van der Putten, Eric, van Triest, Baukelien, Bergman, Andries M., Beijnen, Jos H.
Published in Cancer chemotherapy and pharmacology (01.06.2021)
Published in Cancer chemotherapy and pharmacology (01.06.2021)
Get full text
Journal Article
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab
Kicken, Mart P., Deenen, Maarten J., Moes, Dirk J. A. R., Hendrikx, Jeroen J. M. A., van den Borne, Ben E. E. M., Dumoulin, Daphne W., van der Wekken, Anthonie J., van den Heuvel, Michiel M., ter Heine, Rob
Published in Targeted oncology (01.09.2024)
Published in Targeted oncology (01.09.2024)
Get full text
Journal Article
Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan
Moes, Dirk J. A. R., Hendrikx, Jeroen J. M. A., Guchelaar, Henk-Jan, Mathijssen, Ron H. J., Bakker, J. L., Dezentjé, Vincent O., de Rouw, Nikki, van Erp, Nielka P., Smit, Egbert F., van den Heuvel, Michel M., Munnink, Thijs H. Oude, van Kats, Maartje, Croes, Sander, Kroep, Judith R., Zwaveling, Juliette, ter Heine, Rob
Published in Targeted oncology (01.09.2024)
Published in Targeted oncology (01.09.2024)
Get full text
Journal Article
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology
Chatelut, Etienne, Hendrikx, Jeroen J. M. A., Martin, Jennifer, Ciccolini, Joseph, Moes, Dirk Jan A. R.
Published in Pharmacology research & perspectives (01.04.2021)
Published in Pharmacology research & perspectives (01.04.2021)
Get full text
Journal Article
Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model
Siebinga, Hinke, de Wit-van der Veen, Berlinda J., de Vries-Huizing, Daphne M. V., Vogel, Wouter V., Hendrikx, Jeroen J. M. A., Huitema, Alwin D. R.
Published in EJNMMI physics (24.04.2024)
Published in EJNMMI physics (24.04.2024)
Get full text
Journal Article
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
ter Heine, Rob, van den Heuvel, Michel M., Piet, Berber, Deenen, Maarten J., van der Wekken, Anthonie J., Hendriks, Lizza E. L., Croes, Sander, van Geel, Robin M. J. M., Jansman, Frank G. A., Boshuizen, Rogier C., Franssen, Eric J. F., Smit, Arthur A. J., Dumoulin, Daphne W., Oude Munnink, Thijs H., Smit, Egbert F., Derijks, Hieronymus J., van der Leest, Cor H., Hendrikx, Jeroen J. M. A., Moes, Dirk J. A. R., de Rouw, Nikki
Published in Targeted oncology (01.05.2023)
Published in Targeted oncology (01.05.2023)
Get full text
Journal Article